Breye Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
November 2022

Breye Therapeutics is a clinical stage biopharmaceutical company pursuing a mission to develop novel oral therapies for the treatment of retinal vascular diseases.

Breye Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
November 2022

Breye Therapeutics is a clinical stage biopharmaceutical company pursuing a mission to develop novel oral therapies for the treatment of retinal vascular diseases.

Breye Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
November 2022

Breye Therapeutics is a clinical stage biopharmaceutical company pursuing a mission to develop novel oral therapies for the treatment of retinal vascular diseases.